Are there subtypes of the inositol 1,4,5-trisphosphate receptor?
- 1 July 1990
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 269 (1) , 211-216
- https://doi.org/10.1042/bj2690211
Abstract
We have compared the properties of the [3H]Ins(1,4,5)P3-binding sites from a number of tissues in an attempt to determine if heterogeneity exists within the Ins(1,4,5)P3-receptor family. the binding of Ins(1,4,5)P3 was characterized in detail by using membranes prepared from human uterine smooth muscle and bovine adrenal cortex. Ins(1,4,5)P3 exhibited an approx. 5 times greater affinity for the binding site in adrenal cortex (Kd = 9.81 .+-. 1.92 nM) compared with uterine smooth muscle (Kd = 37.1 .+-. 1.8 nM). The binding was dependent on pH in both tissues, with a maximum at pH8.3; at this pH various inositol phosphates and nucleotides competed for the binding sites with similar potencies on both tissues. However, the binding of Ins(1,4,5)P3 to the uterine smooth-muscle membranes was Ca2+-sensitive, whereas that to the bovine adrenal cortex was not; furthermore, heparin displaced the binding of Ins(1,4,5)P3 in the uterus with an IC50 value (concn. of displacer giving 50% inhibition of specific binding) of 3.9 .mu.g/ml (2.5, 6.4; lower, upper range), compared with a value of 22 (13, 30) .mu.g/ml in adrenal cortex. In view of the ability of Ins(1,4,5)P3 and heparin to distinguish between these binding sites, their effect on other tissues was examined. Ins(1,4,5)P3 showed a similar affinity for receptors located in the bovine cerebellum to those in the bovine adrenal cortex, but heparin displaced Ins(1,4,5)P3 binding with a 5-fold greater affinity from the cerebellum. Ins(1,4,5)P3 had a 2-fold greater affinity for its receptor with human platelets, as compared with human uterus, but heparin was unable to distinguish between these sites. In guinea-pig ileum, Ins(1,4,5)P3 displayed a similar affinity for the receptors in the longitudinal muscle compared with the circular muscle, but heparin could distinguish between these sites. These data show that small differences exist between tissues, but no clear picture is apparent. It is possible that these results reflect tissue-dependent factors such as phosphorylation, the presence of calmedin etc., rather than the presence of receptor subtypes or species difference.This publication has 26 references indexed in Scilit:
- Development of a novel, Ins(1,4,5)P3-specific binding assay: Its use to determine the intracellular concentration of Ins(1,4,5)P3 in unstimulated and vasopressin-stimulated rat hepatocytesCellular Signalling, 1989
- Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesiclesNature, 1989
- Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: Effects of neurotransmitters and depolarizationBiochemical and Biophysical Research Communications, 1988
- Inositol phosphates: proliferation, metabolism and functionPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1988
- Binding sites for inositol trisphosphate in the bovine adrenal cortexBiochemical and Biophysical Research Communications, 1985
- Stepwise enzymatic dephosphorylation of inositol 1,4,5-trisphosphate to inositol in liverNature, 1984
- Inositol trisphosphate, a novel second messenger in cellular signal transductionNature, 1984
- Rapid mobilization of Ca2+ from rat insulinoma microsomes by inositol-1,4,5-trisphosphateNature, 1984
- Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphateNature, 1983
- Cytoplasmic pH and free Mg2+ in lymphocytes.The Journal of cell biology, 1982